Form 8-K - Current report:
SEC Accession No. 0001213900-24-103612
Filing Date
2024-11-29
Accepted
2024-11-27 17:57:41
Documents
14
Period of Report
2024-11-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0222900-8k_abpro.htm   iXBRL 8-K 29069
  Complete submission text file 0001213900-24-103612.txt   248975

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abp-20241121.xsd EX-101.SCH 3855
3 XBRL DEFINITION FILE abp-20241121_def.xml EX-101.DEF 26756
4 XBRL LABEL FILE abp-20241121_lab.xml EX-101.LAB 36996
5 XBRL PRESENTATION FILE abp-20241121_pre.xml EX-101.PRE 25380
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0222900-8k_abpro_htm.xml XML 6079
Mailing Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013
Business Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013 248-890-7200
Abpro Holdings, Inc. (Filer) CIK: 0001893219 (see all company filings)

EIN.: 871013956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41224 | Film No.: 241512688
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)